Percentage of unscheduled cesarean deliveries in which azithromycin was administered within 60 minutes before incision.
Cesarean delivery is a significant risk factor for postpartum uterine infection, associated with a 5-to-10-fold increase in infectious morbidity compared to vaginal delivery1. The use of azithromycin in women undergoing non-elective cesarean deliveries has been shown to reduce the risk of postoperative infections1. Moreover, azithromycin use significantly decreases the rates of endometritis, wound infections, and serious maternal adverse events2. Research by Sanusi et al. indicates that administering azithromycin up to 60 minutes before incision is effective in reducing the risk of postoperative infection, a practice also supported by the American College of Obstetricians and Gynecologists (ACOG) 1,3. It is recommended that the antibiotic be infused before the incision to achieve peak antimicrobial concentrations in the tissue at the time of incision1. Skeith et al. used a TreeAge cost-effectiveness model to compare outcomes of a theoretical cohort of 700,000 women4. They found that for women who undergo cesarean delivery during labor or after membrane rupture adding azithromycin to cephalosporin is less costly and results in better maternal outcomes in the index and subsequent deliveries4.
60 min before Surgical Incision through Surgical Incision
Enumerations 1 and 7 using OBAT (Non-elective cesarean cases.)
Non-elective cesarean patients who received azithromycin within the measure time period.
Both PO Vancomycin and IV routes will be accepted for this measure to pass.
Measure start time:
60 minutes before Surgical Incision time (50235). If no Procedure start time is documented, Surgical AACD Procedure Start will be used. If no Surgical Incision available will use Uterine Incision. If uterine incision is not available will use delivery of neonate 50358, or 50189)
Measure End Time- Earliest time from:
*This measure will include only valid MPOG cases as defined by the Is Valid Case phenotype.
Not Applicable.
All providers signed in during measure time period.
MPOG Concept ID |
Concept Description |
Medication |
|
10048 |
Azithromycin - both PO and IV are accepted |
Measure Time |
|
50002 |
Anesthesia Start |
50009 |
Anesthesia End |
Obstetric Concepts |
|
50181 |
Compliance - Prophylactic antibiotic variance note |
50182 |
Compliance - Prophylactic antibiotic variance detail |
50189 |
Delivery of Neonate 2 |
50235 |
Surgical Incision |
50358 |
Delivery of Neonate |
50622 |
Compliance - Antibiotic Started |
References:
Name |
Institution |
Monica Servin |
University of Michigan |
Brandon Togioka |
Oregon Health and Science University |
Lawrence Tsen |
Harvard Medical School |
Nicole Barrios |
University of Michigan |
Rob Coleman |
University of Michigan |